Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
21 Feb 2023 |
On business and financial situation |
The company releases the Integrated Report for the year 2022
|
Download |
|
21 Feb 2023 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
23 Nov 2022 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of its 2022 Capital Markets Day
|
Download |
|
04 Nov 2022 |
On business and financial situation |
The Company releases the first nine months 2022 financial results presentation
|
Download |
|
04 Nov 2022 |
On business and financial situation |
The Company releases the press release related to the first nine months of 2022 financial results
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
12 Jan 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 5 January and 11 January 2024
|
Download |
|
05 Jan 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 29 December 2023 and 4 January 2024
|
Download |
|
29 Dec 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 22 December and 28 December 2023
|
Download |
|
22 Dec 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 December and 21 December 2023
|
Download |
|
15 Dec 2023 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 11 December and 14 December 2023
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
04 Apr 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the first quarter of 2019
|
Download |
|
19 Mar 2019 |
R&D: new licenses, patents and registered trademarks |
ROVI Announces Positive Topline Results from Phase 3 study of Doria® in Patients with Schizophrenia
|
Download |
|
26 Feb 2019 |
Informe Anual de Remuneraciones de los Consejeros |
ROVI releases the 2018 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
26 Feb 2019 |
Informe Anual de Gobierno Corporativo |
ROVI releases the 2018 Annual Corporate Governance Report
|
Download |
|
26 Feb 2019 |
Otros sobre gobierno corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
